H.I.G. Capital ("H.I.G."), a leading global alternative investment firm with over $45 billion of equity capital under management, is pleased to announce that one of its affiliates has made a strategic equity investment into Rising Pharma Holdings and Casper Pharma (collectively, “Rising Pharmaceuticals” or the “Company”), a leading provider of generic and specialty pharmaceuticals in the United States.

Rising Pharmaceuticals and its affiliates is a provider of generic and specialty-branded pharmaceuticals. Rising focuses on the development, regulatory, and commercial aspects of the product life cycle while outsourcing manufacturing to its network of 23+ strategic CMO and CDO partners. The Company is based in New Brunswick, New Jersey. For more information about the Company, please visit www.risingpharma.com.

H.I.G. Capital Completes Strategic Investment In Rising Pharmaceuticals

Description

Company Information

H.I.G. Capital Completes Strategic Investment In Rising Pharmaceuticals

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Company Information